[Effect of the method of treatment on mean survival time of patients with glial brain tumors].
In the years 1976-1981 54 patients were treated for malignant glial tumours confirmed by histological examination. The purpose of the reported analysis was a comparison of the mean survival time and the mean time of survival without evidence of recurrence in 3 groups of patients. In group I of 13 patients not treated surgically but receiving only conservative management the mean survival time was 7.4 weeks. In group II treated surgically but without other therapy this time was 29.2 weeks. In group III in which the patients were operated on and treated with chemotherapy and radiotherapy this time was 58.9 weeks. The differences between the groups were statistically significant. Similarly, the mean survival time without recurrence was significantly longer in the group receiving comprehensive treatment than in the group treated only surgically (46.5 vs 18.0 weeks).
D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000401:mortality* / Q000628:therapy; D003037:Cobalt Radioisotopes / Q000008:administration & dosage; D004806:Ependymoma / Q000401:mortality* / Q000628:therapy; D005260:Female; D005910:Glioma / Q000401:mortality* / Q000628:therapy; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D013997:Time Factors
D003037:Cobalt Radioisotopes; D008130:Lomustine
Wpływ sposobu leczenia na średni czas przezycia chorych z glejopochodnymi guzami mózgu.